Romel Somwar

Title: Romel Somwar: Innovator in Cancer Research

Introduction

Romel Somwar is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research through his innovative work on pharmaceutical compounds. His research focuses on developing treatments for proliferative diseases, particularly through the inhibition of specific proteins involved in cancer progression.

Latest Patents

Romel Somwar holds a patent for "Substituted pyridazines as EGFR and/or KRAS inhibitors." This invention is directed to pyridazinone compounds of formula (I) and furan compounds of formula (II). The patent includes pharmaceutical compositions of these compounds, kits containing them, methods of synthesis, and a method of treatment for proliferative diseases by administering a therapeutically effective amount of the compounds. Both classes of compounds were identified through screening of a collection of small molecule libraries. He has 1 patent to his name.

Career Highlights

Somwar is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts his research. His work is pivotal in the ongoing fight against cancer, contributing to the development of new therapeutic strategies.

Collaborations

Romel Somwar has collaborated with esteemed colleagues such as Hakim Djaballah and Harold E. Varmus. These collaborations enhance the impact of his research and foster innovation in cancer treatment.

Conclusion

Romel Somwar is a dedicated inventor whose work in cancer research is making a difference in the medical field. His innovative approaches to drug development highlight the importance of research in combating diseases.